| Systemic Sclerosis and Related Diseases | Lifetime | 25 | FR 3 | 99.63 |
| Vasculitis and related conditions | Lifetime | 29 | FR 5 | 99.53 |
| Skin Diseases and Diabetes | Lifetime | 17 | FR 1 | 99.03 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 113 | FR 11 | 99.19 |
| Dermatologic Treatments and Research | Lifetime | 77 | FR 4 | 98.94 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 52 | FR 4 | 99.09 |
| Mast cells and histamine | Lifetime | 91 | FR 5 | 98.49 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 74 | FR 10 | 98.78 |
| Eosinophilic Disorders and Syndromes | Lifetime | 159 | FR 14 | 98.60 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 475 | FR 35 | 97.71 |
| Renal Diseases and Glomerulopathies | Lifetime | 635 | FR 46 | 97.22 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 121 | FR 12 | 96.32 |
| Urticaria and Related Conditions | Lifetime | 524 | FR 32 | 95.91 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 808 | FR 34 | 94.79 |
| Autoimmune Bullous Skin Diseases | Lifetime | 891 | FR 61 | 94.54 |
| Connective Tissue Growth Factor Research | Lifetime | 210 | FR 11 | 90.40 |
| Dupuytren's Contracture and Treatments | Lifetime | 648 | FR 31 | 73.78 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 951 | FR 53 | 69.73 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 23 | FR 3 | 98.82 |
| Mast cells and histamine | 2021-2025 | 51 | FR 4 | 95.27 |
| Dermatologic Treatments and Research | 2021-2025 | 116 | FR 4 | 94.58 |
| Vasculitis and related conditions | 2021-2025 | 204 | FR 29 | 93.26 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 156 | FR 10 | 92.02 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 697 | FR 35 | 89.99 |
| Health, Medicine and Society | 2021-2025 | 195 | FR 133 | 81.47 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 109 | FR 23 | 88.68 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 379 | FR 21 | 86.31 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 413 | FR 35 | 84.98 |
| Skin Diseases and Diabetes | 2021-2025 | 110 | FR 4 | 76.43 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 759 | FR 46 | 80.36 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 653 | FR 32 | 76.40 |
| Healthcare Systems and Practices | 2021-2025 | 663 | FR 398 | 68.94 |
| Connective Tissue Growth Factor Research | 2021-2025 | 83 | FR 4 | 64.57 |
| Dermatological and Skeletal Disorders | 2021-2025 | 699 | FR 47 | 45.71 |
